Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
ASSETS
Cash and due from banks
Interest-bearing deposits in banks
Other short-term investments
Cash and cash equivalents
Investment securities available for sale
Investment securities held to maturity, net of allowance for credit losses of $13 and $14 at September 30, 2021 and December 31, 2020, respectively
Other investments
Loans held for sale
Loans held for sale - discontinued operations
Loans held for investment
Less: Allowance for loan losses
Loans held for investment, net
Premises held for sale - discontinued operations
Premises and equipment, net
Bank owned life insurance
Goodwill - discontinued operations
Goodwill and intangible assets, net
Goodwill
Other intangibles, net
Other real estate owned
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Deposits:
Noninterest-bearing demand
Interest-bearing checking
Savings
Money market
Time
Brokered deposits
Deposits to be assumed - discontinued operations
Total deposits
Deposits to be assumed - discontinued operations
Total deposits
Federal funds purchased
Securities sold under agreements to repurchase - discontinued operations
Federal Home Loan Bank borrowings
Long-term debt
Lease liabilities - discontinued operations
Other liabilities
Total liabilities
SHAREHOLDERS' EQUITY
Preferred Stock, no par value - 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2021 and December 31, 2020
Common stock, no par value - 100,000,000 shares authorized; 20,305,109 and 20,394,912 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively
Retained earnings
Accumulated other comprehensive income
Total shareholders' equity
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support